Exploring the use of nanocarrier systems to deliver the magical molecule; Curcumin and its derivatives

Journal of Controlled Release

Volumn 225, Issue , 2016, Pages 1-30

  Mehanny, Mina ^a   Hathout, Rania M ^a   Geneidi, Ahmed S ^a   Mansour, Samar ^a,b  

^a African Union Organization St Abbassia   (Egypt)

^b German University in Cairo   (Egypt)

Author keywords

Curcumin; Curcuminoids; Drug delivery; Nanocarriers

Indexed keywords

BIOMEDICAL ENGINEERING; CONTROLLED DRUG DELIVERY; DRUG DELIVERY;

AQUEOUS SOLUBILITY; CHEMICAL INSTABILITY; CURCUMIN; CURCUMINOIDS; DELIVERY SYSTEMS; NANO-CARRIERS;

BIOCHEMISTRY;

CARRIER PROTEIN; CHITOSAN NANOPARTICLE; CURCUMIN; DENDRIMER; LIPOSOME; MESOPOROUS SILICA NANOPARTICLE; NANOCARRIER; NIOSOME; SOLID LIPID NANOPARTICLE; DRUG CARRIER; NANOPARTICLE;

ANTIINFLAMMATORY ACTIVITY; CATARACTOGENESIS; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG METABOLISM; DRUG SOLUBILITY; HUMAN; MICROEMULSION; NANOEMULSION; NANOTECHNOLOGY; PHOTODEGRADATION; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; ANIMAL;

ANIMALS; CURCUMIN; DRUG CARRIERS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84955515803     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.01.018     Document Type: Review

References (335)

1. H.A. Vogel, and J. Pelletier Curcumin-biological and medicinal properties J. Pharmacol. 2 1815 50
2. J. Milobedeska, S. Kostanecki, and V. Lampe Structure of curcumin Ber. Dtsch. Chem. Ges. 43 1910 2163 2170
3. V. Lampe, and J. Milobedeska Studien über curcumin Ber. Dtsch. Chem. Ges. 46 1913 2235 2240
4. B.B. Aggarwal, H. Ichikawa, P. Garodia, P. Weerasinghe, G. Sethi, I.D. Bhatt, M.K. Pandey, S. Shishodia, and M.G. Nair From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer Expert Opin. Ther. Targets 10 2006 87 118
5. B.B. Aggarwal, and K.B. Harikumar Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Int. J. Biochem. Cell Biol. 41 2009 40 59
6. P. Anand, S.G. Thomas, A.B. Kunnumakkara, C. Sundaram, K.B. Harikumar, B. Sung, S.T. Tharakan, K. Misra, I.K. Priyadarsini, K.N. Rajasekharan, and B.B. Aggarwal Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature Biochem. Pharmacol. 76 2008 1590 1611
7. W.H. Lee, C.Y. Loo, P.M. Young, D. Traini, R.S. Mason, and R. Rohanizadeh Recent advances in curcumin nanoformulation for cancer therapy Expert Opin. Drug Deliv. 11 2014 1183 1201
8. N. Apetz, G. Munch, S. Govindaraghavan, and E. Gyengesi Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease - a translational perspective CNS Neurol. Disord. Drug Targets. 13 2014 1175 1191
9. A. Kochi, H.J. Lee, S.M. Vithanarachchi, V. Padmini, M.J. Allen, and M.H. Lim Inhibitory activity of curcumin derivatives towards metal-free and metal-induced amyloid-beta aggregation Curr. Alzheimer Res. 12 2015 415 423
10. M.H. Kim, S.H. Kim, and W.M. Yang Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease Planta Med. 80 2014 1249 1258
11. S. Mourtas, A.N. Lazar, E. Markoutsa, C. Duyckaerts, and S.G. Antimisiaris Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease Eur. J. Med. Chem. 80 2014 175 183
12. W.H. Lee, C.Y. Loo, M. Bebawy, F. Luk, R.S. Mason, and R. Rohanizadeh Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century Curr. Neuropharmacol. 11 2013 338 378
13. H. Lv, J. Liu, L. Wang, H. Zhang, S. Yu, Z. Li, F. Jiang, Y. Niu, J. Yuan, X. Cui, and W. Wang Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson's disease Cell Biochem. Biophys. 70 2014 1433 1438
14. S. Chiu, K.J. Terpstra, Y. Bureau, J. Hou, H. Raheb, Z. Cernvosky, V. Badmeav, J. Copen, M. Husni, and M. Woodbury-Farina Liposomal-formulated curcumin [Lipocurc] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug platform J. Complement Integr. Med. 10 2013
15. M. Mohajeri, M. Sadeghizadeh, F. Najafi, and M. Javan Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair Neuropharmacology 2015
16. D.S. Kim, J.Y. Kim, and Y. Han Curcuminoids in neurodegenerative diseases Recent Pat. CNS Drug Discov. 7 2012 184 204
17. K. Schmitz, J. Barthelmes, L. Stolz, S. Beyer, O. Diehl, and I. Tegeder "Disease modifying nutricals" for multiple sclerosis Pharmacol. Ther. 148 2015 85 113
18. A. Sahebkar Dual effect of curcumin in preventing atherosclerosis: the potential role of pro-oxidant-antioxidant mechanisms Nat. Prod. Res. 29 2015 491 492
19. S. Chuengsamarn, S. Rattanamongkolgul, B. Phonrat, R. Tungtrongchitr, and S. Jirawatnotai Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial J. Nutr. Biochem. 25 2014 144 150
20. S.T. Hasan, J.M. Zingg, P. Kwan, T. Noble, D. Smith, and M. Meydani Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice Atherosclerosis 232 2014 40 51
21. J.M. Zingg, S.T. Hasan, and M. Meydani Molecular mechanisms of hypolipidemic effects of curcumin Biofactors 39 2013 101 121
22. S. Biswas, J.W. Hwang, P.A. Kirkham, and I. Rahman Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease Curr. Med. Chem. 20 2013 1496 1530
23. S.J. Moghaddam, P. Barta, S.G. Mirabolfathinejad, Z. mmar-Aouchiche, N.T. Garza, T.T. Vo, R.A. Newman, B.B. Aggarwal, C.M. Evans, M.J. Tuvim, R. Lotan, and B.F. Dickey Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice Carcinogenesis 30 2009 1949 1956
24. M. Suzuki, T. Betsuyaku, Y. Ito, K. Nagai, N. Odajima, C. Moriyama, Y. Nasuhara, and M. Nishimura Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice Am. J. Physiol. Lung Cell. Mol. Physiol. 296 2009 L614 L623
25. Y. Yang, X. Wu, Z. Wei, Y. Dou, D. Zhao, T. Wang, D. Bian, B. Tong, Y. Xia, Y. Xia, and Y. Dai Oral curcumin has anti-arthritic efficacy through somatostatin generation via cAMP/PKA and Ca(2 +)/CaMKII signaling pathways in the small intestine Pharmacol. Res. 95-96 2015 71 81
26. R. Arora, A. Kuhad, I.P. Kaur, and K. Chopra Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats Eur. J. Pain 19 2015 940 952
27. B. Chandran, and A. Goel A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis Phytother. Res. 26 2012 1719 1725
28. S.F. Nabavi, R. Thiagarajan, L. Rastrelli, M. Daglia, E. Sobarzo-Sanchez, H. Alinezhad, and S.M. Nabavi Curcumin: a natural product for diabetes and its complications Curr. Top. Med. Chem. 2015
29. S. Rivera-Mancia, M.C. Lozada-Garcia, and J. Pedraza-Chaverri Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications Eur. J. Pharmacol. 756 2015 30 37
30. M.A. Morsy, and M.A. El-Moselhy Mechanisms of the protective effects of curcumin against indomethacin-induced gastric ulcer in rats Pharmacology 91 2013 267 274
31. L. Pari, D. Tewas, and J. Eckel Role of curcumin in health and disease Arch. Physiol. Biochem. 114 2008 127 149
32. N. Kerdsakundee, S. Mahattanadul, and R. Wiwattanapatapee Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit(R) EPO solid dispersions for gastric ulcer treatment Eur. J. Pharm. Biopharm. 2015
33. S.K. Yadav, A.K. Sah, R.K. Jha, P. Sah, and D.K. Shah Turmeric (curcumin) remedies gastroprotective action Pharmacogn. Rev. 7 2013 42 46
34. H. Jiang, Z. Wang, Y. Wang, K. Xie, Q. Zhang, Q. Luan, W. Chen, and D. Liu Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action Prog. Neuro-Psychopharmacol. Biol. Psychiatry 47 2013 33 39
35. M.K. Bhutani, M. Bishnoi, and S.K. Kulkarni Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes Pharmacol. Biochem. Behav. 92 2009 39 43
36. M.D. King, D.J. McCracken, F.M. Wade, S.E. Meiler, C.H. Alleyne Jr., and K.M. Dhandapani Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice J. Neurosurg. 115 2011 116 123
37. P. Prakash, A. Misra, W.R. Surin, M. Jain, R.S. Bhatta, R. Pal, K. Raj, M.K. Barthwal, and M. Dikshit Anti-platelet effects of curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis Thromb. Res. 127 2011 111 118
38. R. Srivastava, M. Dikshit, R.C. Srimal, and B.N. Dhawan Anti-thrombotic effect of curcumin Thromb. Res. 40 1985 413 417
39. B.H. Shah, Z. Nawaz, S.A. Pertani, A. Roomi, H. Mahmood, S.A. Saeed, and A.H. Gilani Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2 + signaling Biochem. Pharmacol. 58 1999 1167 1172
40. V.H. Ferreira, A. Nazli, S.E. Dizzell, K. Mueller, and C. Kaushic The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2 PLoS One 10 2015 e0124903
41. U. Gandapu, R.K. Chaitanya, G. Kishore, R.C. Reddy, and A.K. Kondapi Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro PLoS One 6 2011 e23388
42. W.M. El-Refaie, Y.S. Elnaggar, M.A. El-Massik, and O.Y. Abdallah Novel curcumin-loaded gel-core hyaluosomes with promising burn-wound healing potential: development, in-vitro appraisal and in-vivo studies Int. J. Pharm. 486 2015 88 98
43. D. Mehrabani, M. Farjam, B. Geramizadeh, N. Tanideh, M. Amini, and M.R. Panjehshahin The healing effect of curcumin on burn wounds in rat World J. Plast. Surg. 4 2015 29 35
44. D. Akbik, M. Ghadiri, W. Chrzanowski, and R. Rohanizadeh Curcumin as a wound healing agent Life Sci. 116 2014 1 7
45. N.M. Kadasa, H. Abdallah, M. Afifi, and S. Gowayed Hepatoprotective effects of curcumin against diethyl nitrosamine induced hepatotoxicity in albino rats Asian Pac. J. Cancer Prev. 16 2015 103 108
46. W.R. Garcia-Nino, and J. Pedraza-Chaverri Protective effect of curcumin against heavy metals-induced liver damage Food Chem. Toxicol. 69 2014 182 201
47. C. Girish, and S.C. Pradhan Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice J. Pharmacol. Pharmacother. 3 2012 149 155
48. T.P. Huynh, S.N. Mann, and N.A. Mandal Botanical compounds: effects on major eye diseases Evid. Based Complement. Alternat. Med. 2013 2013 549174
49. S.C. Ozgen, D. Dokmeci, M. Akpolat, C.H. Karadag, O. Gunduz, H. Erbas, O. Benian, C. Uzal, and F.N. Turan The protective effect of curcumin on ionizing radiation-induced cataractogenesis in rats Balkan Med. J 29 2012 358 363
50. C.N. Grama, P. Suryanarayana, M.A. Patil, G. Raghu, N. Balakrishna, M.N. Kumar, and G.B. Reddy Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model PLoS One 8 2013 e78217
51. P. Anand, C. Sundaram, S. Jhurani, A.B. Kunnumakkara, and B.B. Aggarwal Curcumin and cancer: an "old-age" disease with an "age-old" solution Cancer Lett. 267 2008 133 164
52. G. Bar-Sela, R. Epelbaum, and M. Schaffer Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications Curr. Med. Chem. 17 2010 190 197
53. S.C. Gupta, J.H. Kim, S. Prasad, and B.B. Aggarwal Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals Cancer Metastasis Rev. 29 2010 405 434
54. J. Ravindran, S. Prasad, and B.B. Aggarwal Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 11 2009 495 510
55. S. Shishodia, M.M. Chaturvedi, and B.B. Aggarwal Role of curcumin in cancer therapy Curr. Probl. Cancer 31 2007 243 305
56. P. Anand, C. Sundaram, S. Jhurani, A.B. Kunnumakkara, and B.B. Aggarwal Curcumin and cancer: an "old-age" disease with an "age-old" solution Cancer Lett. 267 2008 133 164
57. B.B. Aggarwal, S.C. Gupta, and J.H. Kim Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey Blood 119 2012 651 665
58. A. Kumar, S. Dhawan, N.J. Hardegen, and B.B. Aggarwal Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation Biochem. Pharmacol. 55 1998 775 783
59. P. Anand, S.G. Thomas, A.B. Kunnumakkara, C. Sundaram, K.B. Harikumar, B. Sung, S.T. Tharakan, K. Misra, I.K. Priyadarsini, K.N. Rajasekharan, and B.B. Aggarwal Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature Biochem. Pharmacol. 76 2008 1590 1611
60. P. Lopez-Bergami, E. Lau, and Z. Ronai Emerging roles of ATF2 and the dynamic AP1 network in cancer Nat. Rev. Cancer 10 2010 65 76
61. R. Eferl, and E.F. Wagner AP-1: a double-edged sword in tumorigenesis Nat. Rev. Cancer 3 2003 859 868
62. B.K. Prusty, and B.C. Das Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin Int. J. Cancer 113 2005 951 960
63. S. Singh, and B.B. Aggarwal Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected] J. Biol. Chem. 270 1995 24995 25000
64. S. Shishodia, P. Potdar, C.G. Gairola, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 Carcinogenesis 24 2003 1269 1279
65. B.B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R.A. Newman, C.E. Bueso-Ramos, and J.E. Price Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice Clin. Cancer Res. 11 2005 7490 7498
66. M. Zheng, S. Ekmekcioglu, E.T. Walch, C.H. Tang, and E.A. Grimm Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells Melanoma Res. 14 2004 165 171
67. A. Chen, and J. Xu Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR Am. J. Physiol. Gastrointest. Liver Physiol. 288 2005 G447 G456
68. S.J. Thomas, J.A. Snowden, M.P. Zeidler, and S.J. Danson The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours Br. J. Cancer 113 2015 365 371
69. A.C. Bharti, N. Donato, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells J. Immunol. 171 2003 3863 3871
70. B.B. Aggarwal, S. Shishodia, S.K. Sandur, M.K. Pandey, and G. Sethi Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72 2006 1605 1621
71. R.A. Sharma, A.J. Gescher, and W.P. Steward Curcumin: the story so far Eur. J. Cancer 41 2005 1955 1968
72. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
73. H.H. Tonnesen, M. Masson, and T. Loftsson Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability Int. J. Pharm. 244 2002 127 135
74. S. Fujisawa, T. Atsumi, M. Ishihara, and Y. Kadoma Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds Anticancer Res. 24 2004 563 569
75. N.A. Kasim, M. Whitehouse, C. Ramachandran, M. Bermejo, H. Lennernas, A.S. Hussain, H.E. Junginger, S.A. Stavchansky, K.K. Midha, V.P. Shah, and G.L. Amidon Molecular properties of WHO essential drugs and provisional biopharmaceutical classification Mol. Pharm. 1 2004 85 96
76. C.R.A. Souza, S.F. Osme, and M.B.A. Gloria Stability of curcuminoid pigments in model systems J. Food Process. Preserv. 21 1997 353 363
77. C. Mohanty, and S.K. Sahoo The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 31 2010 6597 6611
78. J.K. Lin, M.H. Pan, and S.Y. Lin-Shiau Recent studies on the biofunctions and biotransformations of curcumin Biofactors 13 2000 153 158
79. Y.J. Wang, M.H. Pan, A.L. Cheng, L.I. Lin, Y.S. Ho, C.Y. Hsieh, and J.K. Lin Stability of curcumin in buffer solutions and characterization of its degradation products J. Pharm. Biomed. Anal. 15 1997 1867 1876
80. T.H. Marczylo, R.D. Verschoyle, D.N. Cooke, P. Morazzoni, W.P. Steward, and A.J. Gescher Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine Cancer Chemother. Pharmacol. 60 2007 171 177
81. B. Wahlstrom, and G. Blennow A study on the fate of curcumin in the rat Acta Pharmacol. Toxicol. (Copenh) 43 1978 86 92
82. C.R. Ireson, D.J. Jones, S. Orr, M.W. Coughtrie, D.J. Boocock, M.L. Williams, P.B. Farmer, W.P. Steward, and A.J. Gescher Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine Cancer Epidemiol. Biomark. Prev. 11 2002 105 111
83. M.H. Pan, T.M. Huang, and J.K. Lin Biotransformation of curcumin through reduction and glucuronidation in mice Drug Metab. Dispos. 27 1999 486 494
84. G.M. Holder, J.L. Plummer, and A.J. Ryan The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat Xenobiotica 8 1978 761 768
85. V. Ravindranath, and N. Chandrasekhara Metabolism of curcumin - studies with [3H]curcumin Toxicology 22 1981 337 344
86. S.K. Sandur, M.K. Pandey, B. Sung, K.S. Ahn, A. Murakami, G. Sethi, P. Limtrakul, V. Badmaev, and B.B. Aggarwal Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism Carcinogenesis 28 2007 1765 1773
87. E. Pfeiffer, S.I. Hoehle, S.G. Walch, A. Riess, A.M. Solyom, and M. Metzler Curcuminoids form reactive glucuronides in vitro J. Agric. Food Chem. 55 2007 538 544
88. N. Dhillon, B.B. Aggarwal, R.A. Newman, R.A. Wolff, A.B. Kunnumakkara, J.L. Abbruzzese, C.S. Ng, V. Badmaev, and R. Kurzrock Phase II trial of curcumin in patients with advanced pancreatic cancer Clin. Cancer Res. 14 2008 4491 4499
89. C.D. Lao, M.T. Ruffin, D. Normolle, D.D. Heath, S.I. Murray, J.M. Bailey, M.E. Boggs, J. Crowell, C.L. Rock, and D.E. Brenner Dose escalation of a curcuminoid formulation BMC Complement. Altern. Med. 6 2006 10
90. Z. Ma, A. Haddadi, O. Molavi, A. Lavasanifar, R. Lai, and J. Samuel Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin J. Biomed. Mater. Res. A 86 2008 300 310
91. A. Shakeri, and A. Sahebkar Nanotechnology: a successful approach to improve oral bioavailability of phytochemicals Recent Pat. Drug Deliv. Formul. 2015
92. R. Jeetah, A. Bhaw-Luximon, and D. Jhurry Nanopharmaceutics: phytochemical-based controlled or sustained drug-delivery systems for cancer treatment J. Biomed. Nanotechnol. 10 2014 1810 1840
93. K.M. Gharpure, S.Y. Wu, C. Li, G. Lopez-Berestein, and A.K. Sood Nanotechnology: future of oncotherapy Clin. Cancer Res. 21 2015 3121 3130
94. M.Z. Ahmad, S.A. Alkahtani, S. Akhter, F.J. Ahmad, J. Ahmad, M.S. Akhtar, N. Mohsin, and B.A. bdel-Wahab Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art J. Drug Target. 2015 1 21
95. M. Sun, X. Su, B. Ding, X. He, X. Liu, A. Yu, H. Lou, and G. Zhai Advances in nanotechnology-based delivery systems for curcumin Nanomedicine (London) 7 2012 1085 1100
96. O. Naksuriya, S. Okonogi, R.M. Schiffelers, and W.E. Hennink Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment Biomaterials 35 2014 3365 3383
97. N. Ghalandarlaki, A.M. Alizadeh, and S. shkani-Esfahani Nanotechnology-applied curcumin for different diseases therapy Biomed. Res. Int. 2014 2014 394264
98. W.E. Bawarski, E. Chidlowsky, D.J. Bharali, and S.A. Mousa Emerging nanopharmaceuticals Nanomedicine 4 2008 273 282
99. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Curcumin nanoformulations: a future nanomedicine for cancer Drug Discov. Today 17 2012 71 80
100. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
101. Y. Barenholz Doxil(R)-the first FDA-approved nano-drug: lessons learned J. Control. Release 160 2012 117 134
102. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomedicine 1 2006 297 315
103. M. Nasr, I. Taha, and R.M. Hathout Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route Drug Deliv. 20 2013 311 318
104. A.P. Nayak, W. Tiyaboonchai, S. Patankar, B. Madhusudhan, and E.B. Souto Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment Colloids Surf. B: Biointerfaces 81 2010 263 273
105. M. Slingerland, H.J. Guchelaar, and H. Gelderblom Liposomal drug formulations in cancer therapy: 15 years along the road Drug Discov. Today 17 2012 160 166
106. V. Sethi, H. Onyuksel, and I. Rubinstein Liposomal vasoactive intestinal peptide Methods Enzymol. 391 2005 377 395
107. X. Chen, L.Q. Zou, J. Niu, W. Liu, S.F. Peng, and C.M. Liu The stability, sustained release and cellular antioxidant activity of curcumin nanoliposomes Molecules 20 2015 14293 14311
108. A.N. Lazar, S. Mourtas, I. Youssef, C. Parizot, A. Dauphin, B. Delatour, S.G. Antimisiaris, and C. Duyckaerts Curcumin-conjugated nanoliposomes with high affinity for abeta deposits: possible applications to Alzheimer disease Nanomedicine 9 2013 712 721
109. A. Karewicz, D. Bielska, A. Loboda, B. Gzyl-Malcher, J. Bednar, A. Jozkowicz, J. Dulak, and M. Nowakowska Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives Colloids Surf. B: Biointerfaces 109 2013 307 316
110. N.M. Rogers, M.D. Stephenson, A.R. Kitching, J.D. Horowitz, and P.T. Coates Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells Br. J. Pharmacol. 166 2012 194 209
111. N.P. Aditya, G. Chimote, K. Gunalan, R. Banerjee, S. Patankar, and B. Madhusudhan Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice Exp. Parasitol. 131 2012 292 299
112. Y.L. Lin, Y.K. Liu, N.M. Tsai, J.H. Hsieh, C.H. Chen, C.M. Lin, and K.W. Liao A lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells Nanomedicine 8 2012 318 327
113. C. Li, Y. Zhang, T. Su, L. Feng, Y. Long, and Z. Chen Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin Int. J. Nanomedicine 7 2012 5995 6002
114. H. Agashe, K. Sahoo, P. Lagisetty, and V. Awasthi Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats Colloids Surf. B: Biointerfaces 84 2011 329 337
115. F. Re, I. Cambianica, C. Zona, S. Sesana, M. Gregori, R. Rigolio, F.B. La, F. Nicotra, G. Forloni, A. Cagnotto, M. Salmona, M. Masserini, and G. Sancini Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model Nanomedicine 7 2011 551 559
116. M. Takahashi, S. Uechi, K. Takara, Y. Asikin, and K. Wada Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin J. Agric. Food Chem. 57 2009 9141 9146
117. N.K. Narayanan, D. Nargi, C. Randolph, and B.A. Narayanan Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice Int. J. Cancer 125 2009 1 8
118. C. Chen, T.D. Johnston, H. Jeon, R. Gedaly, P.P. McHugh, T.G. Burke, and D. Ranjan An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells Int. J. Pharm. 366 2009 133 139
119. D. Wang, M.S. Veena, K. Stevenson, C. Tang, B. Ho, J.D. Suh, V.M. Duarte, K.F. Faull, K. Mehta, E.S. Srivatsan, and M.B. Wang Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway Clin. Cancer Res. 14 2008 6228 6236
120. R.L. Thangapazham, A. Puri, S. Tele, R. Blumenthal, and R.K. Maheshwari Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells Int. J. Oncol. 32 2008 1119 1123
121. L. Li, F.S. Braiteh, and R. Kurzrock Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis Cancer 104 2005 1322 1331
122. M.N. Azmin, A.T. Florence, R.M. Handjani-Vila, J.F. Stuart, G. Vanlerberghe, and J.S. Whittaker The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice J. Pharm. Pharmacol. 37 1985 237 242
123. M. Malhotra, and N.K. Jain Niosomes as drug carriers Indian Drugs-Bombay 31 1994 81
124. K.M. Kazi, A.S. Mandal, N. Biswas, A. Guha, S. Chatterjee, M. Behera, and K. Kuotsu Niosome: a future of targeted drug delivery systems J. Adv. Pharm. Technol. Res. 1 2010 374 380
125. Y. Rahimpour, and H. Hamishehkar Niosomes as Carrier in Dermal Drug Delivery 2012 INTECH Open Access Publisher
126. H. Schreier, and J. Bouwstra Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery J. Control. Release 30 1994 1 15
127. F. Aqil, R. Munagala, J. Jeyabalan, and M.V. Vadhanam Bioavailability of phytochemicals and its enhancement by drug delivery systems Cancer Lett. 334 2013 133 141
128. N.R. Khan, M.S. Harun, A. Nawaz, N. Harjoh, and T.W. Wong Nanocarriers and their actions to improve skin permeability and transdermal drug delivery Curr. Pharm. Des. 21 2015 2848 2866
129. N. Rungphanichkul, U. Nimmannit, W. Muangsiri, and P. Rojsitthisak Preparation of curcuminoid niosomes for enhancement of skin permeation Pharmazie 66 2011 570 575
130. K. Kumar, and A.K. Rai Development and evaluation of proniosome-encapsulated curcumin for transdermal administration Trop. J. Pharm. Res. 10 2011 697 703
131. S. Mandal, C. Banerjee, S. Ghosh, J. Kuchlyan, and N. Sarkar Modulation of the photophysical properties of curcumin in nonionic surfactant (Tween-20) forming micelles and niosomes: a comparative study of different microenvironments J. Phys. Chem. B 117 2013 6957 6968
132. M.R. Gasco Lipid nanoparticles: perspectives and challenges Adv. Drug Deliv. Rev. 59 2007 377 378
133. B. Siekmann, and K. Westesen Submicron-sized parenteral carrier systems based on solid lipids Pharm. Pharmacol. Lett. 1 1992 123 126
134. S. Nunes, R. Madureira, D. Campos, B. Sarmento, A.M. Gomes, M. Pintado, and F. Reis Solid lipid nanoparticles as oral delivery systems of phenolic compounds: overcoming pharmacokinetic limitations for nutraceutical applications Crit. Rev. Food Sci. Nutr. 2015 0
135. C. Puglia, A. Offerta, C. Carbone, F. Bonina, R. Pignatello, and G. Puglisi Lipid nanocarriers (LNC) and their applications in ocular drug delivery Curr. Med. Chem. 22 2015 1589 1602
136. S.P. Vyas, S. Rai, R. Paliwal, P.N. Gupta, K. Khatri, A.K. Goyal, and B. Vaidya Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: one step up in nanotechnology Curr. Nanosci. 4 2008 30 44
137. S. Martins, B. Sarmento, D.C. Ferreira, and E.B. Souto Lipid-based colloidal carriers for peptide and protein delivery - liposomes versus lipid nanoparticles Int. J. Nanomedicine 2 2007 595 607
138. E.B. Souto A special issue on lipid-based delivery systems (liposomes, lipid nanoparticles, lipid matrices and medicines) J. Biomed. Nanotechnol. 5 2009 315 316
139. E.B. Souto, and R.H. Muller Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes Handb. Exp. Pharmacol. 115-141 2010
140. H.A. Hazzah, R.M. Farid, M.M. Nasra, M.A. El-Massik, and O.Y. Abdallah Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: development and characterization Int. J. Pharm. 492 2015 248 257
141. R. Arora, A. Kuhad, I.P. Kaur, and K. Chopra Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats Eur. J. Pain 19 2015 940 952
142. P. Ramalingam, and Y.T. Ko Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations Pharm. Res. 32 2015 389 402
143. M.H. Rahman, M. Ramanathan, and V. Sankar Preparation, characterization and in vitro cytotoxicity assay of curcumin loaded solid lipid nanoparticle in IMR32 neuroblastoma cell line Pak. J. Pharm. Sci. 27 2014 1281 1285
144. H. Ji, J. Tang, M. Li, J. Ren, N. Zheng, and L. Wu Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin Drug Deliv. 1-12 2014
145. J. Sun, C. Bi, H.M. Chan, S. Sun, Q. Zhang, and Y. Zheng Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability Colloids Surf. B: Biointerfaces 111 2013 367 375
146. P. Wang, L. Zhang, H. Peng, Y. Li, J. Xiong, and Z. Xu The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo Mater. Sci. Eng C. Mater. Biol. Appl. 33 2013 4802 4808
147. P. Dadhaniya, C. Patel, J. Muchhara, N. Bhadja, N. Mathuria, K. Vachhani, and M.G. Soni Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies Food Chem. Toxicol. 49 2011 1834 1842
148. V. Kakkar, S. Singh, D. Singla, S. Sahwney, A.S. Chauhan, G. Singh, and I.P. Kaur Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 878 2010 3427 3431
149. R.S. Mulik, J. Monkkonen, R.O. Juvonen, K.R. Mahadik, and A.R. Paradkar Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis Int. J. Pharm. 398 2010 190 203
150. K. Sou, S. Inenaga, S. Takeoka, and E. Tsuchida Loading of curcumin into macrophages using lipid-based nanoparticles Int. J. Pharm. 352 2008 287 293
151. P. Ramalingam, and Y.T. Ko Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations Pharm. Res. 32 2015 389 402
152. O.M. Koo, I. Rubinstein, and H. Onyuksel Role of nanotechnology in targeted drug delivery and imaging: a concise review Nanomedicine 1 2005 193 212
153. P. Kumari, B. Ghosh, and S. Biswas Nanocarriers for cancer-targeted drug delivery J. Drug Target. 2015 1 13
154. S.S. Bansal, M. Goel, F. Aqil, M.V. Vadhanam, and R.C. Gupta Advanced drug delivery systems of curcumin for cancer chemoprevention Cancer Prev. Res. (Phila) 4 2011 1158 1171
155. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, B.A. Le, and V. Preat PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 161 2012 505 522
156. S. Fredenberg, M. Wahlgren, M. Reslow, and A. Axelsson The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - a review Int. J. Pharm. 415 2011 34 52
157. R.A. Jain The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 21 2000 2475 2490
158. M.F. Sadat Tabatabaei, K. Nejati-Koshki, A. Akbarzadeh, M.R. Yamchi, M. Milani, N. Zarghami, V. Zeighamian, A. Rahimzadeh, S. Alimohammadi, Y. Hanifehpour, and S.W. Joo PLGA-based nanoparticles as cancer drug delivery systems Asian Pac. J. Cancer Prev. 15 2014 517 535
159. J. Shaikh, D.D. Ankola, V. Beniwal, D. Singh, and M.N. Kumar Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Eur. J. Pharm. Sci. 37 2009 223 230
160. M.M. Yallapu, D.M. Maher, V. Sundram, M.C. Bell, M. Jaggi, and S.C. Chauhan Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth J. Ovarian Res. 3 2010 11
161. M.S. Cartiera, E.C. Ferreira, C. Caputo, M.E. Egan, M.J. Caplan, and W.M. Saltzman Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin Mol. Pharm. 7 2010 86 93
162. M.M. Yallapu, B.K. Gupta, M. Jaggi, and S.C. Chauhan Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells J. Colloid Interface Sci. 351 2010 19 29
163. M.R.v. der, L.J. Vehmeijer, R.J. Kok, G. Storm, and E.V.v. Gaal Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status Adv. Drug Deliv. Rev. 65 2013 1284 1298
164. A. Mathew, T. Fukuda, Y. Nagaoka, T. Hasumura, H. Morimoto, Y. Yoshida, T. Maekawa, K. Venugopal, and D.S. Kumar Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease PLoS One 7 2012 e32616
165. W. Punfa, S. Yodkeeree, P. Pitchakarn, C. Ampasavate, and P. Limtrakul Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells Acta Pharmacol. Sin. 33 2012 823 831
166. D. Ghosh, S.T. Choudhury, S. Ghosh, A.K. Mandal, S. Sarkar, A. Ghosh, K.D. Saha, and N. Das Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat Chem. Biol. Interact. 195 2012 206 214
167. N.M. Khalil, T.C.d. Nascimento, D.M. Casa, L.F. Dalmolin, A.C.d. Mattos, I. Hoss, M.A. Romano, and R.M. Mainardes Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats Colloids Surf. B: Biointerfaces 101 2013 353 360
168. K.L. Nair, A.K. Thulasidasan, G. Deepa, R.J. Anto, and G.S. Kumar Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier Int. J. Pharm. 425 2012 44 52
169. R. Klippstein, J.T. Wang, R.I. El-Gogary, J. Bai, F. Mustafa, N. Rubio, S. Bansal, W.T. Al-Jamal, and K.T. Al-Jamal Passively targeted curcumin-loaded PEGylated PLGA nanocapsules for colon cancer therapy in vivo Small 11 2015 4704 4722
170. A.A. Metwally, and R.M. Hathout Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery Mol. Pharm. 12 2015 2800 2810
171. V. Grabovac, and A. Bernkop-Schnurch Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine Drug Dev. Ind. Pharm. 33 2007 767 774
172. X. Xie, Q. Tao, Y. Zou, F. Zhang, M. Guo, Y. Wang, H. Wang, Q. Zhou, and S. Yu PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms J. Agric. Food Chem. 59 2011 9280 9289
173. Y.M. Tsai, W.L. Chang-Liao, C.F. Chien, L.C. Lin, and T.H. Tsai Effects of polymer molecular weight on relative oral bioavailability of curcumin Int. J. Nanomedicine 7 2012 2957 2966
174. P. Anand, H.B. Nair, B. Sung, A.B. Kunnumakkara, V.R. Yadav, R.R. Tekmal, and B.B. Aggarwal Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo Biochem. Pharmacol. 79 2010 330 338
175. B.N. Waghela, A. Sharma, S. Dhumale, S.M. Pandey, and C. Pathak Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells PLoS One 10 2015 e0117526
176. C.O. Sullivan, and C. Birkinshaw In vitro degradation of insulin-loaded poly (n-butylcyanoacrylate) nanoparticles Biomaterials 25 2004 4375 4382
177. K. Farion, M.H. Osmond, L. Hartling, K. Russell, T. Klassen, E. Crumley, and N. Wiebe Tissue adhesives for traumatic lacerations in children and adults CochraneDatabase Syst. Rev. 2002 CD003326
178. F. Ren, R. Chen, Y. Wang, Y. Sun, Y. Jiang, and G. Li Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer Pharm. Res. 28 2011 897 906
179. M. Bagad, and Z.A. Khan Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in wistar rats Int. J. Nanomedicine 10 2015 3921 3935
180. M. Sun, Y. Gao, C. Guo, F. Cao, Z. Song, Y. Xi, A. Yu, A. Li, and G. Zhai Enhancement of transport of curcumin to brain in mice by poly (n-butylcyanoacrylate) nanoparticle J. Nanoparticle Res. 12 2010 3111 3122
181. R.S. Mulik, J. Monkkonen, R.O. Juvonen, K.R. Mahadik, and A.R. Paradkar ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model Mol. Pharm. 7 2010 815 825
182. J. Duan, Y. Zhang, S. Han, Y. Chen, B. Li, M. Liao, W. Chen, X. Deng, J. Zhao, and B. Huang Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles Int. J. Pharm. 400 2010 211 220
183. A. Bernkop-Schnurch, and S. Dunnhaupt Chitosan-based drug delivery systems Eur. J. Pharm. Biopharm. 81 2012 463 469
184. K. Nagpal, S.K. Singh, and D.N. Mishra Chitosan nanoparticles: a promising system in novel drug delivery Chem. Pharm. Bull. (Tokyo) 58 2010 1423 1430
185. R.K. Das, N. Kasoju, and U. Bora Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells Nanomedicine 6 2010 153 160
186. F. Wang, W. Huang, L. Jiang, and B. Tang Quantitative determination of proteins based on strong fluorescence enhancement in curcumin-chitosan-proteins system J. Fluoresc. 22 2012 615 622
187. L. Mazzarino, C. Travelet, S. Ortega-Murillo, I. Otsuka, I. Pignot-Paintrand, E. Lemos-Senna, and R. Borsali Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications J. Colloid Interface Sci. 370 2012 58 66
188. A. Kumar, M. Glaum, N. El-Badri, S. Mohapatra, E. Haller, S. Park, L. Patrick, L. Nattkemper, D. Vo, and D.F. Cameron Initial observations of cell-mediated drug delivery to the deep lung Cell Transplant. 20 2011 609 618
189. A. Anitha, S. Maya, N. Deepa, K.P. Chennazhi, S.V. Nair, H. Tamura, and R. Jayakumar Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells Carbohydr. Polym. 83 2011 452 461
190. A. Anitha, S. Maya, N. Deepa, K.P. Chennazhi, S.V. Nair, and R. Jayakumar Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery J. Biomater. Sci. Polym. Ed. 2011
191. I. Dimitrov, B. Trzebicka, A.H. Müller, A. Dworak, and C.B. Tsvetanov Thermosensitive water-soluble copolymers with doubly responsive reversibly interacting entities Prog. Polym. Sci. 32 2007 1275 1343
192. D. Schmaljohann Thermo- and pH-responsive polymers in drug delivery Adv. Drug Deliv. Rev. 58 2006 1655 1670
193. N.S. Rejinold, P.R. Sreerekha, K.P. Chennazhi, S.V. Nair, and R. Jayakumar Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery Int. J. Biol. Macromol. 49 2011 161 172
194. N.S. Rejinold, M. Muthunarayanan, V.V. Divyarani, P.R. Sreerekha, K.P. Chennazhi, S.V. Nair, H. Tamura, and R. Jayakumar Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery J. Colloid Interface Sci. 360 2011 39 51
195. F. Akhtar, M.M. Rizvi, and S.K. Kar Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice Biotechnol. Adv. 30 2012 310 320
196. J. Zhang, Q. Tang, X. Xu, and N. Li Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery Int. J. Pharm. 448 2013 168 174
197. J. Liu, L. Xu, C. Liu, D. Zhang, S. Wang, Z. Deng, W. Lou, H. Xu, Q. Bai, and J. Ma Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake Carbohydr. Polym. 90 2012 16 22
198. G. Loch-Neckel, L. Santos-Bubniak, L. Mazzarino, A.V. Jacques, B. Moccelin, M.C. Santos-Silva, and E. Lemos-Senna Orally administered chitosan-coated polycaprolactone nanoparticles containing curcumin attenuate metastatic melanoma in the lungs J. Pharm. Sci. 2015
199. A. Anitha, V.G. Deepagan, V.D. Rani, D. Menon, S.V. Nair, and R. Jayakumar Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles Carbohydr. Polym. 84 2011 1158 1164
200. P. Udompornmongkol, and B.H. Chiang Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications J. Biomater. Appl. 2015
201. A. Yadav, V. Lomash, M. Samim, and S.J. Flora Curcumin encapsulated in chitosan nanoparticles: a novel strategy for the treatment of arsenic toxicity Chem. Biol. Interact. 199 2012 49 61
202. M. Esmaili, S.M. Ghaffari, Z. Moosavi-Movahedi, M.S. Atri, A. Sharifizadeh, M. Farhadi, R. Yousefi, J.M. Chobert, T. Haertl, and A.A. Moosavi-Movahedi Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application LWT Food Sci. Technol. 44 2011 2166 2172
203. R.M. Hathout, and M.K. Omran Gelatin-based particulate systems in ocular drug delivery Pharm. Dev. Technol. 1-8 2015
204. A.O. Elzoghby, W.M. Samy, and N.A. Elgindy Albumin-based nanoparticles as potential controlled release drug delivery systems J. Control. Release 157 2012 168 182
205. R.M. Hathout, and M.K. Omran Gelatin-based particulate systems in ocular drug delivery Pharm. Dev. Technol. 1-8 2015
206. G.V. Patil Biopolymer albumin for diagnosis and in drug delivery Drug Dev. Res. 58 2003 219 247
207. P. Bourassa, C.D. Kanakis, P. Tarantilis, M.G. Pollissiou, and H.A. Tajmir-Riahi Resveratrol, genistein, and curcumin bind bovine serum albumin J. Phys. Chem. B 114 2010 3348 3354
208. J. Cortes, and C. Saura Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer Eur. J. Cancer Suppl. 8 2010 1 10
209. A.V. Jithan, K. Madhavi, M. Madhavi, and K. Prabhakar Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer Int. J. Pharm. Investig. 1 2011 119
210. H. Wartlick, B. Spankuch-Schmitt, K. Strebhardt, J. Kreuter, and K. Langer Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles J. Control. Release 96 2004 483 495
211. T.H. Kim, H.H. Jiang, Y.S. Youn, C.W. Park, K.K. Tak, S. Lee, H. Kim, S. Jon, X. Chen, and K.C. Lee Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity Int. J. Pharm. 403 2011 285 291
212. A. Jithan, K. Madhavi, M. Madhavi, and K. Prabhakar Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer Int. J. Pharm. Investig. 1 2011 119 125
213. G. Gong, Q. Pan, K. Wang, R. Wu, Y. Sun, and Y. Lu Curcumin-incorporated albumin nanoparticles and its tumor image Nanotechnology 26 2015 045603
214. H.A. Aziz, K.K. Peh, and Y.T. Tan Solubility of core materials in aqueous polymeric solution effect on microencapsulation of curcumin Drug Dev. Ind. Pharm. 33 2007 1263 1272
215. F. Cilurzo, F. Selmin, C.G. Gennari, L. Montanari, and P. Minghetti Application of methyl methacrylate copolymers to the development of transdermal or loco-regional drug delivery systems Expert Opin. Drug Deliv. 11 2014 1033 1045
216. P. Dandekar, R. Dhumal, R. Jain, D. Tiwari, G. Vanage, and V. Patravale Toxicological evaluation of pH-sensitive nanoparticles of curcumin: acute, sub-acute and genotoxicity studies Food Chem. Toxicol. 48 2010 2073 2089
217. D. Prajakta, J. Ratnesh, K. Chandan, S. Suresh, S. Grace, V. Meera, and P. Vandana Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer J. Biomed. Nanotechnol. 5 2009 445 455
218. A. Beloqui, R. Coco, P.B. Memvanga, B. Ucakar, R.A. des, and V. Preat pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease Int. J. Pharm. 473 2014 203 212
219. S.K. Jain, G. Rai, D.K. Saraf, and G.P. Agrawal Albendazole microspheres for colonic delivery Pharm. Technol. 2004 67
220. M. Madhavi, K. Madhavi, and A.V. Jithan Preparation and in vitro/in vivo characterization of curcumin microspheres intended to treat colon cancer J. Pharm. Bioallied Sci. 4 2012 164 171
221. K. Omidfar, F. Khorsand, and A.M. Darziani New analytical applications of gold nanoparticles as label in antibody based sensors Biosens. Bioelectron. 43 2013 336 347
222. J.R. Nicol, D. Dixon, and J.A. Coulter Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics Nanomedicine (London) 10 2015 1315 1326
223. J. Rajesh, M. Rajasekaran, G. Rajagopal, and P. Athappan Analytical methods to determine the comparative DNA binding studies of curcumin-Cu(II) complexes Spectrochim. Acta A Mol. Biomol. Spectrosc. 97 2012 223 230
224. K. Kumar, D. Gnanaprakash, K. Mayilvaganan, C. Arunraj, and S. Mohankumar Chitosan-gold nanoparticles as delivery systems for curcumins Int. J. Pharm. Sci. Res. 3 2012 4533
225. S. Manju, and K. Sreenivasan Gold nanoparticles generated and stabilized by water soluble curcuminΓÇôpolymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells J. Colloid Interface Sci. 368 2012 144 151
226. M.J. Sweet, and I. Singleton Silver nanoparticles: a microbial perspective Adv. Appl. Microbiol. 77 2011 115 133
227. A. Ravindran, P. Chandran, and S.S. Khan Biofunctionalized silver nanoparticles: advances and prospects Colloids Surf. B: Biointerfaces 105 2013 342 352
228. C.A. dos Santos, M.M. Seckler, A.P. Ingle, I. Gupta, S. Galdiero, M. Galdiero, A. Gade, and M. Rai Silver nanoparticles: therapeutical uses, toxicity, and safety issues J. Pharm. Sci. 103 2014 1931 1944
229. K. Varaprasad, Y.M. Mohan, K. Vimala, and K. Mohana Raju Synthesis and characterization of hydrogel-silver nanoparticle-curcumin composites for wound dressing and antibacterial application J. Appl. Polym. Sci. 121 2011 784 796
230. K.E. El, M. Abiad, Z.G. Kassaify, and D. Patra Green synthesis of curcumin conjugated nanosilver for the applications in nucleic acid sensing and anti-bacterial activity Colloids Surf. B: Biointerfaces 127 2015 274 280
231. S. Inagaki, Y. Fukushima, and K. Kuroda Synthesis of highly ordered mesoporous materials from a layered polysilicate, journal of the chemical society Chem. Commun. 1993 680 682
232. C.T. Kresge, M.E. Leonowicz, W.J. Roth, J.C. Vartuli, and J.S. Beck Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism Nature 359 1992 710 712
233. Y. Zhao, J.L. Vivero-Escoto, I.I. Slowing, B.G. Trewyn, and V.S. Lin Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery Expert Opin. Drug Deliv. 7 2010 1013 1029
234. S. Baek, R.K. Singh, D. Khanal, K.D. Patel, E.J. Lee, K.W. Leong, W. Chrzanowski, and H.W. Kim Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles Nanoscale 7 2015 14191 14216
235. D. Douroumis, I. Onyesom, M. Maniruzzaman, and J. Mitchell Mesoporous silica nanoparticles in nanotechnology Crit. Rev. Biotechnol. 33 2013 229 245
236. J.L. Vivero-Escoto, I.I. Slowing, B.G. Trewyn, and V.S. Lin Mesoporous silica nanoparticles for intracellular controlled drug delivery Small 6 2010 1952 1967
237. J. Lu, M. Liong, J.I. Zink, and F. Tamanoi Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs Small 3 2007 1341 1346
238. Y. Gao, Y. Chen, X. Ji, X. He, Q. Yin, Z. Zhang, J. Shi, and Y. Li Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles ACS Nano 5 2011 9788 9798
239. H. Chen, Z. Zhen, W. Tang, T. Todd, Y.J. Chuang, L. Wang, Z. Pan, and J. Xie Label-free luminescent mesoporous silica nanoparticles for imaging and drug delivery Theranostics 3 2013 650
240. M. Colilla, B. González, and M.a. Vallet-Regí Mesoporous silica nanoparticles for the design of smart delivery nanodevices Biomater. Sci. 1 2013 114 134
241. J. Lu, Z. Li, J.I. Zink, and F. Tamanoi In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification Nanomed.: Nanotechnol., Biol. Med. 8 2012 212 220
242. H. Mekaru, J. Lu, and F. Tamanoi Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy Adv. Drug Deliv. Rev. 95 2015 40 49
243. L. Ma'mani, S. Nikzad, H. Kheiri-Manjili, S. Al-Musawi, M. Saeedi, S. Askarlou, A. Foroumadi, and A. Shafiee Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy Eur. J. Med. Chem. 83 2014 646 654
244. S. Jambhrunkar, Z. Qu, A. Popat, J. Yang, O. Noonan, L. Acauan, Y. Ahmad Nor, C. Yu, and S. Karmakar Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicity 11 2014 3642 3655
245. S. Kim, R. Diab, O. Joubert, N. Canilho, and A. Pasc Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin Colloids Surf. B: Biointerfaces 140 2015 161 168
246. D. Jin, K.W. Park, J.H. Lee, K. Song, J.G. Kim, M.L. Seo, and J.H. Jung The selective immobilization of curcumin onto the internal surface of mesoporous hollow silica particles by covalent bonding and its controlled release J. Mater. Chem. 21 2011 3641 3645
247. S. Jambhrunkar, S. Karmakar, A. Popat, M. Yu, and C. Yu Mesoporous silica nanoparticles enhance the cytotoxicity of curcumin RSC Adv. 4 2014 709 712
248. S. Kim, S. Philippot, S. Fontanay, R.E. Duval, E. Lamouroux, N. Canilho, and A. Pasc pH-and glutathione-responsive release of curcumin from mesoporous silica nanoparticles coated using tannic acid-Fe (iii) complex RSC Adv. 5 2015 90550 90558
249. P. Huang, B. Zeng, Z. Mai, J. Deng, Y. Fang, W. Huang, H. Zhang, J. Yuan, Y. Wei, and W. Zhou Novel drug delivery nanosystems based on out-inside bifunctionalized mesoporous silica yolk shell magnetic nanostars used as nanocarriers for curcumin J. Mater. Chem. B 2016
250. A.A. Metwally, and R.M. Hathout Replacing microemulsion formulations experimental solubility studies with in-silico methods comprising molecular dynamics and docking experiments Chem. Eng. Res. Des. 104 2015 453 456
251. R.M. Hathout, and A.H. Elshafeey Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker Eur. J. Pharm. Biopharm. 82 2012 230 240
252. R.M. Hathout, and T.J. Woodman Applications of NMR in the characterization of pharmaceutical microemulsions J. Control. Release 161 2012 62 72
253. R.M. Hathout Using principal component analysis in studying the transdermal delivery of a lipophilic drug from soft nano-colloidal carriers to develop a quantitative composition effect permeability relationship Pharm. Dev. Technol. 19 2014 598 604
254. N. Anton, and T.F. Vandamme Nano-emulsions and micro-emulsions: clarifications of the critical differences Pharm. Res. 28 2011 978 985
255. L. He, G.L. Wang, and Q. Zhang An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile Int. J. Pharm. 250 2003 45 50
256. Q. Huang, H. Yu, and Q. Ru Bioavailability and delivery of nutraceuticals using nanotechnology J. Food Sci. 75 2010 R50 R57
257. M. Kumar, A. Misra, A.K. Babbar, A.K. Mishra, P. Mishra, and K. Pathak Intranasal nanoemulsion based brain targeting drug delivery system of risperidone Int. J. Pharm. 358 2008 285 291
258. M.H. Lee, H.Y. Lin, H.C. Chen, and J.L. Thomas Ultrasound mediates the release of curcumin from microemulsions Langmuir 24 2008 1707 1713
259. D. Mou, H. Chen, D. Du, C. Mao, J. Wan, H. Xu, and X. Yang Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs Int. J. Pharm. 353 2008 270 276
260. F. Podlogar, M. Gasperlin, M. Tomsic, A. Jamnik, and M.B. Rogac Structural characterisation of water-Tween 40/Imwitor 308-isopropyl myristate microemulsions using different experimental methods Int. J. Pharm. 276 2004 115 128
261. P. Santos, A.C. Watkinson, J. Hadgraft, and M.E. Lane Application of microemulsions in dermal and transdermal drug delivery Skin Pharmacol. Physiol. 21 2008 246 259
262. J. Seki, S. Sonoke, A. Saheki, H. Fukui, H. Sasaki, and T. Mayumi A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting Int. J. Pharm. 273 2004 75 83
263. A.K. Sharma, T. Garg, A.K. Goyal, and G. Rath Role of microemuslsions in advanced drug delivery Artif. Cells Nanomed. Biotechnol. 1-9 2015
264. C. Solans, P. Izquierdo, J. Nolla, N. Azemar, and M.J. Garcia-Celma Nano-emulsions Curr. Opin. Colloid Interface Sci. 10 2005 102 110
265. H.C. Vadlamudi, H. Narendran, T. Nagaswaram, G. Yaga, J. Thanniru, and P.R. Yalavarthi Microemulsions based transdermal drug delivery systems Curr. Drug Discov. Technol. 11 2014 169 180
266. A. Teichmann, S. Heuschkel, U. Jacobi, G. Presse, R.H. Neubert, W. Sterry, and J. Lademann Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream Eur. J. Pharm. Biopharm. 67 2007 699 706
267. J. Cui, B. Yu, Y. Zhao, W. Zhu, H. Li, H. Lou, and G. Zhai Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems Int. J. Pharm. 371 2009 148 155
268. S. Dokania, and A.K. Joshi Self-microemulsifying drug delivery system (SMEDDS) - challenges and road ahead Drug Deliv. 2014
269. S. Setthacheewakul, S. Mahattanadul, N. Phadoongsombut, W. Pichayakorn, and R. Wiwattanapatapee Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats Eur. J. Pharm. Biopharm. 76 2010 475 485
270. H. Rachmawati, D.K. Budiputra, and R. Mauludin Curcumin nanoemulsion for transdermal application: formulation and evaluation Drug Dev. Ind. Pharm. 41 2015 560 566
271. S. Anuchapreeda, Y. Fukumori, S. Okonogi, and H. Ichikawa Preparation of lipid nanoemulsions incorporating curcumin for cancer therapy J. Nanotechnol. 2012 2011
272. H.Y. Lin, J.L. Thomas, H.W. Chen, C.M. Shen, W.J. Yang, and M.H. Lee In vitro suppression of oral squamous cell carcinoma growth by ultrasound-mediated delivery of curcumin microemulsions Int. J. Nanomedicine 7 2012 941 951
273. S. Onoue, H. Takahashi, Y. Kawabata, Y. Seto, J. Hatanaka, B. Timmermann, and S. Yamada Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability J. Pharm. Sci. 99 2010 1871 1881
274. W. Tiyaboonchai, W. Tungpradit, and P. Plianbangchang Formulation and characterization of curcuminoids loaded solid lipid nanoparticles Int. J. Pharm. 337 2007 299 306
275. P. Shukla, P. Dwivedi, P.K. Gupta, and P.R. Mishra Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis Expert Opin. Drug Deliv. 11 2014 1697 1712
276. C.C. Lin, H.Y. Lin, H.C. Chen, M.W. Yu, and M.H. Lee Stability and characterisation of phospholipid-based curcumin-encapsulated microemulsions Food Chem. 116 2009 923 928
277. W. Lin, J.L. Hong, G. Shen, R.T. Wu, Y. Wang, M.T. Huang, H.L. Newmark, Q. Huang, T.O. Khor, T. Heimbach, and A.N. Kong Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition Biopharm. Drug Dispos. 32 2011 65 75
278. H. Arima, Y. Hayashi, T. Higashi, and K. Motoyama Recent advances in cyclodextrin delivery techniques Expert Opin. Drug Deliv. 1-17 2015
279. T. Loftsson, A. Magnusdottir, M. Masson, and J.F. Sigurjonsdottir Self-association and cyclodextrin solubilization of drugs J. Pharm. Sci. 91 2002 2307 2316
280. T. Loftsson, and D. Duchene Cyclodextrins and their pharmaceutical applications Int. J. Pharm. 329 2007 1 11
281. S.p. Menuel, J.P. Joly, B. Courcot, J. Elysée, N.E. Ghermani, and A. Marsura Synthesis and inclusion ability of a bis-β-cyclodextrin pseudo-cryptand towards Busulfan anticancer agent Tetrahedron 63 2007 1706 1714
282. M.E. Davis, and M.E. Brewster Cyclodextrin-based pharmaceutics: past, present and future Nat. Rev. Drug Discov. 3 2004 1023 1035
283. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Beta-cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells Colloids Surf. B: Biointerfaces 79 2010 113 125
284. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Poly(beta-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells Macromol. Biosci. 10 2010 1141 1151
285. V.R. Yadav, S. Suresh, K. Devi, and S. Yadav Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model AAPS PharmSciTech 10 2009 752 762
286. V.R. Yadav, S. Prasad, R. Kannappan, J. Ravindran, M.M. Chaturvedi, L. Vaahtera, J. Parkkinen, and B.B. Aggarwal Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake Biochem. Pharmacol. 80 2010 1021 1032
287. H. Rachmawati, C.A. Edityaningrum, and R. Mauludin Molecular inclusion complex of curcumin-beta-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel AAPS PharmSciTech 14 2013 1303 1312
288. A. Cutrignelli, A. Lopedota, N. Denora, R.M. Iacobazzi, E. Fanizza, V. Laquintana, M. Perrone, V. Maggi, and M. Franco A new complex of curcumin with sulfobutylether-beta-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells J. Pharm. Sci. 103 2014 3932 3940
289. C.M. Keck, and R.H. Muller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16
290. R.H. Muller, C. Jacobs, and O. Kayser Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 2001 3 19
291. B. Sudhakar, K. NagaJyothi, and K.V. Murthy Nanosuspensions as a versatile carrier based drug delivery system - an overview Curr. Drug Deliv. 11 2014 299 305
292. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796
293. S.S. Chavhan, K.C. Petkar, and K.K. Sawant Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects Crit. Rev. Ther. Drug Carrier Syst. 28 2011 447 488
294. Y. Gao, Z. Li, M. Sun, C. Guo, A. Yu, Y. Xi, J. Cui, H. Lou, and G. Zhai Preparation and characterization of intravenously injectable curcumin nanosuspension Drug Deliv. 18 2011 131 142
295. Y. Gao, Z. Li, M. Sun, H. Li, C. Guo, J. Cui, A. Li, F. Cao, Y. Xi, H. Lou, and G. Zhai Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer Drug Dev. Ind. Pharm. 36 2010 1225 1234
296. N.P. Aditya, H. Yang, S. Kim, and S. Ko Fabrication of amorphous curcumin nanosuspensions using beta-lactoglobulin to enhance solubility, stability, and bioavailability Colloids Surf. B: Biointerfaces 127 2015 114 121
297. X.L. Wei, Y.R. Han, L.H. Quan, C.Y. Liu, and Y.H. Liao Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: preparation, characterization and in vivo evaluation Eur. J. Pharm. Sci. 49 2013 286 293
298. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 47 2001 113 131
299. G. Gaucher, M.H. Dufresne, V.P. Sant, N. Kang, D. Maysinger, and J.C. Leroux Block copolymer micelles: preparation, characterization and application in drug delivery J. Control. Release 109 2005 169 188
300. C. Oerlemans, W. Bult, M. Bos, G. Storm, J.F. Nijsen, and W.E. Hennink Polymeric micelles in anticancer therapy: targeting, imaging and triggered release Pharm. Res. 27 2010 2569 2589
301. M. Talelli, C.J. Rijcken, W.E. Hennink, and T. Lammers Polymeric micelles for cancer therapy: 3 C's to enhance efficacy Curr. Opinion Solid State Mater. Sci. 16 2012 302 309
302. Y. Lu, and K. Park Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs Int. J. Pharm. 453 2013 198 214
303. Y. Zhang, Y. Huang, and S. Li Polymeric micelles: nanocarriers for cancer-targeted drug delivery AAPS PharmSciTech 15 2014 862 871
304. H. Cabral, and K. Kataoka Progress of drug-loaded polymeric micelles into clinical studies J. Control. Release 190 2014 465 476
305. Y. Lu, and K. Park Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs Int. J. Pharm. 453 2013 198 214
306. C. Mohanty, S. Acharya, A.K. Mohanty, F. Dilnawaz, and S.K. Sahoo Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy Nanomedicine (London) 5 2010 433 449
307. M. Gou, K. Men, H. Shi, M. Xiang, J. Zhang, J. Song, J. Long, Y. Wan, F. Luo, X. Zhao, and Z. Qian Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo Nanoscale 3 2011 1558 1567
308. L. Song, Y. Shen, J. Hou, L. Lei, S. Guo, and C. Qian Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation Colloids Surf. A Physicochem. Eng. Asp. 390 2011 25 32
309. Z. Song, R. Feng, M. Sun, C. Guo, Y. Gao, L. Li, and G. Zhai Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo J. Colloid Interface Sci. 354 2011 116 123
310. A.B.E. Attia, Z.Y. Ong, J.L. Hedrick, P.P. Lee, P.L.R. Ee, P.T. Hammond, and Y.Y. Yang Mixed micelles self-assembled from block copolymers for drug delivery Curr. Opin. Colloid Interface Sci. 16 2011 182 194
311. E.V. Batrakova, and A.V. Kabanov Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Control. Release 130 2008 98 106
312. D.Y. Alakhova, and A.V. Kabanov Pluronics and MDR reversal: an update Mol. Pharm. 11 2014 2566 2578
313. L. Zhao, J. Du, Y. Duan, Y. Zang, H. Zhang, C. Yang, F. Cao, and G. Zhai Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization Colloids Surf. B: Biointerfaces 97 2012 101 108
314. A. Sahu, N. Kasoju, P. Goswami, and U. Bora Encapsulation of curcumin in Pluronic block copolymer micelles for drug delivery applications J. Biomater. Appl. 25 2011 619 639
315. J. Wang, W. Ma, and P. Tu The mechanism of self-assembled mixed micelles in improving curcumin oral absorption: in vitro and in vivo Colloids Surf. B: Biointerfaces 133 2015 108 119
316. O. Naksuriya, Y. Shi, C.F. van Nostrum, S. Anuchapreeda, W.E. Hennink, and S. Okonogi HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth Eur. J. Pharm. Biopharm. 94 2015 501 512
317. S. Podaralla, R. Averineni, M. Alqahtani, and O. Perumal Synthesis of novel biodegradable methoxy poly(ethylene glycol)-zein micelles for effective delivery of curcumin Mol. Pharm. 9 2012 2778 2786
318. H. Yu, J. Li, K. Shi, and Q. Huang Structure of modified epsilon-polylysine micelles and their application in improving cellular antioxidant activity of curcuminoids Food Funct. 2 2011 373 380
319. Z. Ma, A. Shayeganpour, D.R. Brocks, A. Lavasanifar, and J. Samuel High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin Biomed. Chromatogr. 21 2007 546 552
320. C. Gong, S. Deng, Q. Wu, M. Xiang, X. Wei, L. Li, X. Gao, B. Wang, L. Sun, Y. Chen, Y. Li, L. Liu, Z. Qian, and Y. Wei Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles Biomaterials 34 2013 1413 1432
321. S. Bisht, G. Feldmann, S. Soni, R. Ravi, C. Karikar, A. Maitra, and A. Maitra Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy J. Nanobiotechnol. 5 2007 3
322. S. Bisht, M. Mizuma, G. Feldmann, N.A. Ottenhof, S.M. Hong, D. Pramanik, V. Chenna, C. Karikari, R. Sharma, M.G. Goggins, M.A. Rudek, R. Ravi, A. Maitra, and A. Maitra Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer Mol. Cancer Ther. 9 2010 2255 2264
323. L. Liu, L. Sun, Q. Wu, W. Guo, L. Li, Y. Chen, Y. Li, C. Gong, Z. Qian, and Y. Wei Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis Int. J. Pharm. 443 2013 175 182
324. M. Mehanny, R.M. Hathout, A.S. Geneidi, and S. Mansour Bisdemethoxycurcumin loaded polymeric mixed micelles as potential anti-cancer remedy: preparation, optimization and cytotoxic evaluation in a HepG-2 cell model J. Mol. Liq. 214 2016 162 170
325. H. Namazi, and M. Adeli Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents Biomaterials 26 2005 1175 1183
326. M. Longmire, P.L. Choyke, and H. Kobayashi Dendrimer-based contrast agents for molecular imaging Curr. Top. Med. Chem. 8 2008 1180 1186
327. J. Bugno, H.J. Hsu, and S. Hong Recent advances in targeted drug delivery approaches using dendritic polymers Biomater. Sci. 3 2015 1025 1034
328. S. Svenson Dendrimers as versatile platform in drug delivery applications Eur. J. Pharm. Biopharm. 71 2009 445 462
329. W. Shi, S. Dolai, S. Rizk, A. Hussain, H. Tariq, S. Averick, W. L'Amoreaux, l.A. El, P. Banerjee, and K. Raja Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications Org. Lett. 9 2007 5461 5464
330. A. Abderrezak, P. Bourassa, J.S. Mandeville, R. Sedaghat-Herati, and H.A. Tajmir-Riahi Dendrimers bind antioxidant polyphenols and cisplatin drug PLoS One 7 2012 e33102
331. S. Debnath, D. Saloum, S. Dolai, C. Sun, S. Averick, K. Raja, and E. Fata Dendrimer-curcumin conjugate: a water soluble and effective cytotoxic agent against breast cancer cell lines Anti Cancer Agents Med. Chem. (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 13 2013 1531 1539
332. M.M. Yallapu, M.C. Ebeling, N. Chauhan, M. Jaggi, and S.C. Chauhan Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes Int. J. Nanomedicine 6 2011 2779 2790
333. E. Markatou, V. Gionis, G.D. Chryssikos, S. Hatziantoniou, A. Georgopoulos, and C. Demetzos Molecular interactions between dimethoxycurcumin and Pamam dendrimer carriers Int. J. Pharm. 339 2007 231 236
334. E. Babaei, M. Sadeghizadeh, Z.M. Hassan, M.A. Feizi, F. Najafi, and S.M. Hashemi Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo Int. Immunopharmacol. 12 2012 226 234
335. M.M. Tahmasebi, B. Isacchi, M. Sadeghizadeh, F. Marra, A.R. Bilia, S.J. Mowla, F. Najafi, and E. Babaei Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells Int. J. Nanomedicine 9 2014 403 417